# Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

> **NCT00791895** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 102 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 30

## Key facts

- **NCT ID:** NCT00791895
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06-26
- **Primary completion:** 2004-10-31
- **Final completion:** 2004-11-29
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791895, "Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00791895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*